Report Detail
Global (United States, European Union and China) Imatinib Drugs Market Research Report 2019-2025
- RnM3326521 |
- 18 April, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Imatinib Drugs is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Imatinib Drugs.
This report studies the global market size of Imatinib Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Imatinib Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Apotex Inc.
Novartis
Sanofi S.A.
Cipla Inc.
Mylan Pharms Inc.
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Market Segment by Product Type
Capsules
Tablets
Market Segment by Application
Hospitals
Drug Stores
Other
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Imatinib Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Imatinib Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Imatinib Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Imatinib Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Capsules
- 1.3.3 Tablets
- 1.4 Market Segment by Application
- 1.4.1 Global Imatinib Drugs Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Drug Stores
- 1.4.4 Other
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Imatinib Drugs Market Size
- 2.1.1 Global Imatinib Drugs Revenue 2014-2025
- 2.1.2 Global Imatinib Drugs Sales 2014-2025
- 2.2 Imatinib Drugs Growth Rate by Regions
- 2.2.1 Global Imatinib Drugs Sales by Regions 2014-2019
- 2.2.2 Global Imatinib Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Imatinib Drugs Sales by Manufacturers
- 3.1.1 Imatinib Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Imatinib Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Imatinib Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Imatinib Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Imatinib Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Imatinib Drugs Price by Manufacturers
- 3.4 Key Manufacturers Imatinib Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Imatinib Drugs Market
- 3.6 Key Manufacturers Imatinib Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Capsules Sales and Revenue (2014-2019)
- 4.1.2 Tablets Sales and Revenue (2014-2019)
- 4.2 Global Imatinib Drugs Sales Market Share by Type
- 4.3 Global Imatinib Drugs Revenue Market Share by Type
- 4.4 Imatinib Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Imatinib Drugs Sales by Application
6 United States
- 6.1 United States Imatinib Drugs Breakdown Data by Company
- 6.2 United States Imatinib Drugs Breakdown Data by Type
- 6.3 United States Imatinib Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Imatinib Drugs Breakdown Data by Company
- 7.2 European Union Imatinib Drugs Breakdown Data by Type
- 7.3 European Union Imatinib Drugs Breakdown Data by Application
8 China
- 8.1 China Imatinib Drugs Breakdown Data by Company
- 8.2 China Imatinib Drugs Breakdown Data by Type
- 8.3 China Imatinib Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Imatinib Drugs Breakdown Data by Company
- 9.2 Rest of World Imatinib Drugs Breakdown Data by Type
- 9.3 Rest of World Imatinib Drugs Breakdown Data by Application
- 9.4 Rest of World Imatinib Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Imatinib Drugs Sales by Countries
- 9.4.2 Rest of World Imatinib Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Apotex Inc.
- 10.1.1 Apotex Inc. Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Imatinib Drugs
- 10.1.4 Imatinib Drugs Product Introduction
- 10.1.5 Apotex Inc. Recent Development
- 10.2 Novartis
- 10.2.1 Novartis Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Imatinib Drugs
- 10.2.4 Imatinib Drugs Product Introduction
- 10.2.5 Novartis Recent Development
- 10.3 Sanofi S.A.
- 10.3.1 Sanofi S.A. Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Imatinib Drugs
- 10.3.4 Imatinib Drugs Product Introduction
- 10.3.5 Sanofi S.A. Recent Development
- 10.4 Cipla Inc.
- 10.4.1 Cipla Inc. Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Imatinib Drugs
- 10.4.4 Imatinib Drugs Product Introduction
- 10.4.5 Cipla Inc. Recent Development
- 10.5 Mylan Pharms Inc.
- 10.5.1 Mylan Pharms Inc. Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Imatinib Drugs
- 10.5.4 Imatinib Drugs Product Introduction
- 10.5.5 Mylan Pharms Inc. Recent Development
- 10.6 Glenmark Pharmaceuticals Ltd.
- 10.6.1 Glenmark Pharmaceuticals Ltd. Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Imatinib Drugs
- 10.6.4 Imatinib Drugs Product Introduction
- 10.6.5 Glenmark Pharmaceuticals Ltd. Recent Development
- 10.7 Sun Pharmaceuticals
- 10.7.1 Sun Pharmaceuticals Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Imatinib Drugs
- 10.7.4 Imatinib Drugs Product Introduction
- 10.7.5 Sun Pharmaceuticals Recent Development
- 10.8 Actavis Generics
- 10.8.1 Actavis Generics Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Imatinib Drugs
- 10.8.4 Imatinib Drugs Product Introduction
- 10.8.5 Actavis Generics Recent Development
- 10.9 Dr. Reddy's Laboratories
- 10.9.1 Dr. Reddy's Laboratories Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Imatinib Drugs
- 10.9.4 Imatinib Drugs Product Introduction
- 10.9.5 Dr. Reddy's Laboratories Recent Development
- 10.10 Teva Pharmaceutical Industries Ltd.
- 10.10.1 Teva Pharmaceutical Industries Ltd. Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Imatinib Drugs
- 10.10.4 Imatinib Drugs Product Introduction
- 10.10.5 Teva Pharmaceutical Industries Ltd. Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Imatinib Drugs Sales Channels
- 11.2.2 Imatinib Drugs Distributors
- 11.3 Imatinib Drugs Customers
12 Market Forecast
- 12.1 Global Imatinib Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Imatinib Drugs Sales Forecast by Type
- 12.3 Global Imatinib Drugs Sales Forecast by Application
- 12.4 Imatinib Drugs Forecast by Regions
- 12.4.1 Global Imatinib Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Imatinib Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Imatinib Drugs. Industry analysis & Market Report on Imatinib Drugs is a syndicated market report, published as Global (United States, European Union and China) Imatinib Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Imatinib Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
